We are live on ! Find out more
WP

Woodline Partners Portfolio holdings

AUM $26.4B
1-Year Est. Return 44.85%
This Fund
S&P 500
This Quarter Est. Return
+4.94%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
AUM
$6.98B
AUM Growth
+$857M
Cap. Flow
+$784M
Cap. Flow %
11.24%
Top 10 Hldgs %
16.48%
Holding
878
New
205
Increased
124
Reduced
98
Closed
184

Top Sells

Rank Stock Value
1
TER icon
Teradyne
TER
+$132M
2
QCOM icon
Qualcomm
QCOM
+$77.3M
3
ABT icon
Abbott
ABT
+$69.2M
4
BKNG icon
Booking.com
BKNG
+$67.7M
5
KLAC icon
KLA
KLAC
+$63.2M

Sector Composition

Rank Sector Weight
1 Healthcare 41.18%
2 Technology 29.45%
3 Communication Services 6.73%
4 Industrials 6.43%
5 Financials 4.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BOAS
301
DELISTED
BOA Acquisition Corp.
BOAS
$4.42M 0.06%
450,000
+387,500
+620% +$3.79M
SPOT icon
302
Spotify
SPOT
$101B
$4.41M 0.06%
18,834
-37,358
-66% -$9.35M
PDOT
303
DELISTED
Peridot Acquisition Corp. II
PDOT
$4.38M 0.06%
450,000
BBL
304
DELISTED
BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares)
BBL
$4.36M 0.06%
+72,900
New +$3.97M
OSI
305
DELISTED
Osiris Acquisition Corp.
OSI
$4.36M 0.06%
450,000
MGNX icon
306
MacroGenics
MGNX
$249M
$4.32M 0.06%
269,272
-556,397
-67% -$10.5M
SIEN
307
DELISTED
Sientra, Inc.
SIEN
$4.29M 0.06%
116,860
-65,970
-36% -$3.2M
KRON
308
DELISTED
Kronos Bio
KRON
$4.21M 0.06%
309,597
-191,031
-38% -$2.99M
CVET
309
DELISTED
Covetrus, Inc. Common Stock
CVET
$4.21M 0.06%
+210,669
New +$3.97M
FRPT icon
310
Freshpet
FRPT
$3.44B
$4.21M 0.06%
44,147
-6,948
-14% -$862K
BABA icon
311
Alibaba
BABA
$308B
$4.09M 0.06%
+34,418
New +$5.01M
OBIO icon
312
Orchestra BioMed
OBIO
$252M
$4.07M 0.06%
403,699
LITS
313
Lite Strategy Inc
LITS
$32.9M
$4.03M 0.06%
75,426
+1,077
+1% +$60.1K
OHAAU
314
DELISTED
OPY Acquisition Corp. I Units
OHAAU
$3.96M 0.06%
+400,000
New +$3.99M
DGNU
315
DELISTED
Dragoneer Growth Opportunities Corp. III Class A Ordinary Shares
DGNU
$3.91M 0.06%
400,000
CLYM
316
Climb Bio
CLYM
$710M
$3.9M 0.06%
373,368
-13,856
-4% -$207K
HIII
317
DELISTED
Hudson Executive Investment Corp. III Class A Common Stock
HIII
$3.89M 0.06%
400,000
ASZ
318
DELISTED
Austerlitz Acquisition Corporation II
ASZ
$3.89M 0.06%
400,000
AONC
319
DELISTED
American Oncology Network, Inc. Class A Common Stock
AONC
$3.88M 0.06%
400,000
ARYE
320
DELISTED
ARYA Sciences Acquisition Corp V Class A Ordinary Shares
ARYE
$3.88M 0.06%
400,000
LULU icon
321
lululemon athletica
LULU
$14B
$3.77M 0.05%
+9,641
New +$4.12M
CLAA
322
DELISTED
Colonnade Acquisition Corp. II
CLAA
$3.75M 0.05%
386,122
KURA icon
323
Kura Oncology
KURA
$818M
$3.75M 0.05%
267,683
SHCO
324
DELISTED
Soho House & Co
SHCO
$3.73M 0.05%
292,180
LENZ
325
LENZ Therapeutics
LENZ
$164M
$3.73M 0.05%
42,862

Similar funds

Woodline Partners's Q4 2021 Portfolio in Review

As of Q4 2021, Woodline Partners held 878 positions worth $6.98B, up 14% from $6.12B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Woodline Partners deployed $784M of net new capital in Q4 2021, opening 205 new positions and adding to 124 existing holdings. Its largest new stake was Qorvo: 963,210 shares worth $151M.

By sector, the portfolio is most concentrated in Healthcare at 41% of assets, down from 46% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was KLA, an estimated $63.2M trimmed.

  • Woodline Partners's largest Q4 2021 buy was Qorvo: 963,210 shares worth $151M.
  • Woodline Partners added most to ASML in Q4 2021, an estimated $117M increase.
  • Woodline Partners's biggest Q4 2021 reduction was KLA, cutting an estimated $63.2M.
  • Woodline Partners fully exited Teradyne in Q4 2021, selling an estimated $132M.
  • Woodline Partners's ten largest holdings make up 16% of its $6.98B portfolio in Q4 2021.
  • Woodline Partners opened 205 new positions and closed 184 in Q4 2021.
  • Woodline Partners's portfolio value rose 14% quarter-over-quarter to $6.98B.

Based on Woodline Partners's 13F filing for Q4 2021, filed 14 Feb 2022.